FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to identifying a core region of ND2 responsible for interacting with Src, and can be used in medicine. Peptides are obtained, no more than 20 amino acid residues ND2 region, containing residues 310-321.
EFFECT: invention enables to obtain peptides inhibiting interaction ND2 with Src, that can be used for effective therapy of stroke and pain.
15 cl, 23 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHLORIDE SALT OF PEPTIDE TAT-NR2B9c COMPOSITION, BASED THEREON AND METHODS FOR PRODUCTION THEREOF | 2015 |
|
RU2707885C2 |
| APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
| EFFECTIVE TRANSPORT INTO LEUKOCYTES | 2009 |
|
RU2558240C2 |
| HUMAN RET-BINDING ANTIBODIES AND METHODS OF USE THEREOF | 2020 |
|
RU2821548C2 |
| NOVEL CONSTRUCTIONS OF TRANSPORTERS AND CONJUGATE MOLUCELES WHICH ARE TRASPORTERS OF CARGO-MOLECULES | 2009 |
|
RU2570632C2 |
| NOVEL MOLECULE INHIBITORS OF JNK | 2011 |
|
RU2570417C2 |
| METHODS AND COMPOSITIONS FOR IMPROVED DELIVERY OF MACROMOLECULES | 2009 |
|
RU2522245C2 |
| MIMETIC PEPTIDES | 2013 |
|
RU2662973C2 |
| MODULATOR OF NMDA-RECEPTOR WITH STABILISED SECONDARY STRUCTURE AND ITS USAGE | 2011 |
|
RU2566821C2 |
| MEANS AND METHODS FOR DIAGNOSING AND TREATING MULTIPLE SCLEROSIS | 2012 |
|
RU2601298C2 |
